Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL232060 | 1.00 | TSHR (0.42) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL818646 | 1.00 | TSHR (0.42) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL26406 | 1.00 | TSHR (0.42) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL14760231 | 1.00 | TSHR (0.42) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL26538 | 1.00 | TSHR (0.42) | TSHRTHRBLMNADNM1ALDH1A1 | |
| Octane SCHEMBL18660174 | 1.00 | TSHR (0.42) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL16538101 | 1.00 | TSHR (0.42) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL6534000 | 1.00 | TSHR (0.42) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL21456807 | 1.00 | TSHR (0.42) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL25767 | 1.00 | TSHR (0.42) | TSHRTHRBLMNADNM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260000623-A1 | DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES | CHAN, Hardy Wai Hong (TW) | 2026-01-01 | — | — | US | claimed |
| CN-120154535-A | Ionic liquid anticarious paint with antibacterial and mineralization promoting functions and preparation method thereof | 中国人民解放军空军军医大学 | 2025-06-17 | — | — | CN | claimed |
| CN-119331433-B | High-dispersibility phthalocyanine pigment and preparation method thereof | 淄博福颜化工集团有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119331433-A | High-dispersibility phthalocyanine pigment and preparation method thereof | 淄博福颜化工集团有限公司 | 2025-01-21 | — | — | CN | claimed |
| WO-2024263122-A1 | SUPERHYDROPHOBIC AND SUPEROLEOPHILIC COMPOSITE SPONGE MATERIAL AND THE PRODUCTION METHOD THEREOF | AKDENIZ UNIVERSITESI (TR) | 2024-12-26 | — | — | WO | claimed |
| US-20240352315-A1 | METHODS AND COMPOSITIONS FOR ENHANCED DISPERSION OF PHOSPHOR IN A POLYMERIC MATRIX | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2024-10-24 | — | — | US | claimed |
| EP-4358119-A2 | IMPROVED SELF-ASSEMBLED MONOLAYER BLOCKING WITH INTERMITTENT AIR-WATER EXPOSURE | Applied Materials, Inc. (US) | 2024-04-24 | — | — | EP | claimed |
| US-11903767-B2 | Composite tissue markers detectable via multiple detection modalities | VIEW POINT MEDICAL, INC. (US) | 2024-02-20 | — | — | US | claimed |
| US-11882992-B2 | Composite tissue markers detectable via multiple detection modalities including radiopaque element | VIEW POINT MEDICAL, INC. (US) | 2024-01-30 | — | — | US | claimed |
| CN-112239209-B | Drug delivery via pore-modified mesoporous silica nanoparticles | 奈力生医股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| EP-0748359-B1 | IMPROVED PROCESSIBILITY AND LACING RESISTANCE WHEN SILANIZED PIGMENTS ARE INCORPORATED IN POLYMERS | DU PONT (US) | 1999-08-18 | — | — | EP | claimed |
| EP-0748362-B1 | PROCESS FOR PREPARING SILANIZED TiO 2 PIGMENTS USING A MEDIA MILL | DU PONT (US) | 1997-12-29 | — | — | EP | claimed |
| US-5635326-A | COLORANT-CONTAINING PARTICULATE RESIN AND TITANIUM OXIDE AND AN ALKYL TITANATED TREATED WITH A SILANE-TYPE ORGANIC COMPOUND; SHARPNESS; ANTIFOGGING AGENTS; DURABILITY; COPIERS; ELECTROPHOTOGRAPHY | CANON KABUSHIKI KAISHA (JP) | 1997-06-03 | — | — | US | claimed |
| US-5607994-A | POLYETHYLENE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-03-04 | — | — | US | claimed |
| EP-0748362-A1 | PROCESS FOR PREPARING SILANIZED TiO 2 PIGMENTS USING A MEDIA MILL | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-12-18 | — | — | EP | claimed |
| EP-0748359-A1 | IMPROVED PROCESSIBILITY AND LACING RESISTANCE WHEN SILANIZED PIGMENTS ARE INCORPORATED IN POLYMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-12-18 | — | — | EP | claimed |
| US-5501732-A | Process for preparing silanized TiO2 pigments using a media mill | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-03-26 | — | — | US | claimed |
| EP-0674237-A1 | Electrostatic image-developing toner, fine powdery titanium oxide, and hydrophobic fine powdery titanium oxide | CANON KABUSHIKI KAISHA (JP) | 1995-09-27 | — | — | EP | claimed |
| WO-1995023194-A1 | PROCESS FOR PREPARING SILANIZED TiO2 PIGMENTS USING A MEDIA MILL | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-08-31 | — | — | WO | claimed |
| WO-1995023192-A1 | IMPROVED PROCESSIBILITY AND LACING RESISTANCE WHEN SILANIZED PIGMENTS ARE INCORPORATED IN POLYMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-08-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000623-A1 | DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES | AQP4, ABCB1, SRMS | TSHR 3081/4885THRB 3746/4885LMNA 1004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.